According to Blue Shield Optoelectronics's announcement, the cumulative deviation value of the closing price increase of the company's stock exceeded 30% for 2 consecutive trading days on August 14 and August 17, 2026, which is an abnormal fluctuation in stock trading. After verification, the company, controlling shareholders, actual controllers, etc. did not have any important matters that should be disclosed or not disclosed. In 2025, the company's revenue was 399 million yuan, down 34.53% year on year; net loss was 887.665 million yuan, down 1468.72% year on year. Revenue for the first quarter of 2026 was 88,163 million yuan, down 13.20% year on year; net loss was 8.6643 million yuan, down 271.99% year on year. The company plans to issue shares and pay cash to purchase a controlling interest in Suzhou Lanchuang Technology Co., Ltd. and raise supporting capital. The transaction still requires multiple approvals, and there is an uncertain risk of suspension, suspension or cancellation. As of August 14, 2026, the company's rolling price-earnings ratio was negative, and the stock price fluctuated greatly in the short term, and there is a risk of a pullback after a surge.

According to Blue Shield Optoelectronics's announcement, the cumulative deviation value of the closing price increase of the company's stock exceeded 30% for 2 consecutive trading days on August 14 and August 17, 2026, which is an abnormal fluctuation in stock trading. After verification, the company, controlling shareholders, actual controllers, etc. did not have any important matters that should be disclosed or not disclosed. In 2025, the company's revenue was 399 million yuan, down 34.53% year on year; net loss was 887.665 million yuan, down 1468.72% year on year. Revenue for the first quarter of 2026 was 88,163 million yuan, down 13.20% year on year; net loss was 8.6643 million yuan, down 271.99% year on year. The company plans to issue shares and pay cash to purchase a controlling interest in Suzhou Lanchuang Technology Co., Ltd. and raise supporting capital. The transaction still requires multiple approvals, and there is an uncertain risk of suspension, suspension or cancellation. As of August 14, 2026, the company's rolling price-earnings ratio was negative, and the stock price fluctuated greatly in the short term, and there is a risk of a pullback after a surge.